We are live on ! Find out more
SP

SIH Partners Portfolio holdings

AUM $7.58B
1-Year Est. Return 5.28%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
+5.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.69B
AUM Growth
-$263M
Cap. Flow
-$386M
Cap. Flow %
-14.36%
Top 10 Hldgs %
65.93%
Holding
325
New
55
Increased
42
Reduced
42
Closed
171

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.42%
2 Materials 3.76%
3 Communication Services 3.25%
4 Technology 1.63%
5 Healthcare 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GERN icon
226
Geron
GERN
$911M
-39,868
Closed -$63.4K
GH icon
227
Guardant Health
GH
$19.5B
-10,397
Closed -$443K
GILD icon
228
Gilead Sciences
GILD
$161B
-112,052
Closed -$12.6M
GME icon
229
GameStop
GME
$9.5B
-311,420
Closed -$6.95M
GOOGL icon
230
Alphabet (Google) Class A
GOOGL
$3.91T
-3,291
Closed -$509K
GSG icon
231
CALL
iShares S&P GSCI Commodity-Indexed Trust
GSG
$1.02B
-125,000
Closed -$2.85M
HALO icon
232
Halozyme
HALO
$9.72B
-7,626
Closed -$487K
HCA icon
233
HCA Healthcare
HCA
$84.8B
-1,716
Closed -$593K
HUM icon
234
Humana
HUM
$46.7B
-1,187
Closed -$314K
IBIT icon
235
iShares Bitcoin Trust
IBIT
$47.2B
-8,912
Closed -$417K
IBRX icon
236
ImmunityBio
IBRX
$7.44B
-46,017
Closed -$139K
IDXX icon
237
Idexx Laboratories
IDXX
$42.9B
-533
Closed -$224K
ILMN icon
238
Illumina
ILMN
$29.4B
-10,070
Closed -$799K
IMVT icon
239
Immunovant
IMVT
$8.09B
-10,705
Closed -$183K
INCY icon
240
Incyte
INCY
$23.5B
-14,135
Closed -$856K
ING icon
241
CALL
ING
ING
$93.8B
-404,600
Closed -$7.93M
ING icon
242
PUT
ING
ING
$93.8B
-758,800
Closed -$14.9M
INSM icon
243
Insmed
INSM
$23.2B
-11,415
Closed -$871K
IONS icon
244
Ionis Pharmaceuticals
IONS
$9.35B
-11,999
Closed -$362K
IOVA icon
245
Iovance Biotherapeutics
IOVA
$2.23B
-20,637
Closed -$68.7K
IQV icon
246
IQVIA
IQV
$34.7B
-1,385
Closed -$244K
ISRG icon
247
Intuitive Surgical
ISRG
$121B
-3,583
Closed -$1.77M
JAZZ icon
248
Jazz Pharmaceuticals
JAZZ
$15.9B
-3,739
Closed -$464K
JHX icon
249
James Hardie Industries
JHX
$15.4B
-111,436
Closed -$2.63M
JNJ icon
250
Johnson & Johnson
JNJ
$635B
-47,378
Closed -$7.86M

Similar funds

SIH Partners's Q2 2025 Portfolio in Review

As of Q2 2025, SIH Partners held 325 positions worth $2.69B, down 8.9% from $2.95B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

SIH Partners withdrew a net $386M in Q2 2025, closing 171 positions and reducing 42 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $28.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 14% a quarter earlier, followed by Materials and Communication Services.

Against the trend, SIH Partners opened a new position in Amrize Ltd worth $49.7M.

  • SIH Partners's largest Q2 2025 buy was Amrize Ltd: 1,003,159 shares worth $49.7M.
  • SIH Partners added most to Alibaba in Q2 2025, an estimated $127M increase.
  • SIH Partners's biggest Q2 2025 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $127M.
  • SIH Partners fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q2 2025, selling an estimated $28.1M.
  • SIH Partners's ten largest holdings make up 66% of its $2.69B portfolio in Q2 2025.
  • SIH Partners opened 55 new positions and closed 171 in Q2 2025.
  • SIH Partners's portfolio value fell 8.9% quarter-over-quarter to $2.69B.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.